Table. 1.

Methods used for mock survey for external quality control specimens for hepatitis viral antigen and antibody assessment

Year and trial Method Instruments, manufacturers
2018-1st & 2nd trial ECLIA Cobas e602 modules/E170, Roche
CLIA Architect i2000, Abbott
Centaur XP/XPT, Siemens Healthcare
UniCel DxI 800, Beckman Coulter
EciQ, Ortho-Clinical Diagnostics
FEIA VIDAS, BioMérieux
2019-1st & 2nd trial ECLIA Cobas e602, e801 modules/E170, Roche
CLIA Architect i2000/Alinity i, Abbott
Centaur XP/Atellica IM, Siemens Healthcare
UniCel DxI 800, Beckman Coulter
EciQ, Ortho-Clinical Diagnostics
Centaur XP/Atellica IM, Siemens Healthcare
FEIA VIDAS, BioMérieux

The following instruments were used: Cobas e602/e801 modules, E170 (Roche Diagnostics GmbH, Mannheim, Germany), Architect i2000, Alinity i (Abbott Diagnostics, Abbott Park, IL, USA), Centaur XP/XPT, Atellica IM (Siemens Healthineers, Erlangen, Germany), UniCel DxI 800 (Beckman Coulter Inc., Brea, CA, USA), EciQ (Ortho Clinical Diagnostics, Raritan, NJ, USA), and VIDAS (BioMérieux, Marcy-L'Etoile, France).

Abbreviations: ECLIA, electrochemiluminescence immunoassay; CLIA, chemiluminescence immunoassay; FEIA, fluorescence enzyme immunoassay.

J Lab Med Qual Assur 2020;42:166~176 https://doi.org/10.15263/jlmqa.2020.42.4.166
© Lab Med Qual Assur